Opioid Victims Have a Settlement. Will the Supreme Court Undo It?

Opioid Victims Have a Settlement. Will the Su...

Up next

'The Interview': How Tragedy, Wealth and Trump Shaped JB Pritzker

The governor of Illinois and Trump antagonist has become a national figure for Democrats. Where will that lead? Thoughts? Email us at theinterview@nytimes.com Watch our show on YouTube: youtube.com/@TheInterviewPodcast For transcripts and more, visit: nytimes.com/theinterview Sub ...  Show more

The Case of Kristie Metcalfe

Warning: This episode contains strong language. The Civil Rights Division of the Justice Department — founded to focus on fighting race-based discrimination — has drastically changed the kinds of cases it pursues, dropping or setting aside many already in progress. Sarah Koenig f ...  Show more

Recommended Episodes

Will Big Pharma Ever Face Justice for the Opioid Crisis?
The Daily Show: Ears Edition

The Supreme Court recently blocked a bankruptcy deal that would have given full immunity to the members of the Sackler family who once controlled Purdue Pharma, the maker of OxyContin. Trevor Noah calls out the frustrating contradictions within the initial deal and shares his tho ...  Show more

Ep. 214: Blood Feud - The U.S. v. Elizabeth Holmes
Law360's Pro Say - News & Analysis on Law and the Legal Industry

The upcoming criminal trial of former Theranos CEO Elizabeth Holmes figures to center around one crucial question: Was the blood testing startup’s failure a case of misguided Silicon Valley over-ambition, or was it outright fraud? Law360’s Dorothy Atkins has been covering the The ...  Show more

Only Fun Drugs Should Cost Money
What A Day

The Biden administration on Tuesday shared the first ten prescription drugs that it has chosen for price negotiations through Medicare. The Biden administration will try to lower Medicare prices for the drugs by negotiating with their respective manufacturers to ease the burden o ...  Show more

590. Can $55 Billion End the Opioid Epidemic?
Freakonomics Radio

Thanks to legal settlements with drug makers and distributors, states have plenty of money to boost prevention and treatment. Will it work? (Part two of a two-part series.)

 

< ...  Show more